The global antigout drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Antigout drugs are used to treat gout, a most common form of inflammatory arthritis. The gout is caused owing to high uric acid levels in the blood due to hyperuricemia which results in the formation of monosodium urate crystals. The major factor for the growth of the market is the increasing prevalence of gout across the globe. 

According to the National Center for Biotechnology Information (NCBI),  an estimated 1% to 2% of the population is affected by gout globally. Additionally, men are more likely to get it than women with an estimated five times more in men. Furthermore, gout mostly occurs in men aged 40 and above while it usually only affects women after menopause. Hence, the increasing prevalence of gout is in turn driving the growth of the market during the forecast period.

Some major players in the market include Pfizer Inc., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2019, Unichem Pharmaceuticals (USA), Inc. announced the launch of Allopurinol Tablets. Allopurinol Tablets is the generic version of Zyloprim of Casper Pharma LLC., and is used for the management of patients with signs and symptoms of primary or secondary gout.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Type

o By Application

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape- Pfizer Inc., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd., among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Antigout Drug Market Report by Segment

By Type 

    • Febuxostat

    • Benzbromarone

    • Allopurinol

    • Colchicine

By Application 

    • Acute Gout

    • Chronic Gout

Global Antigout Drug Market Report by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • South Korea

    • Rest of Asia-Pacific 

Rest of the World

    • Latin America 

    • Middle East & Africa